Fucosylation-deficient cells
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsGang Chen, Darya Burakov, James P. Fandl
Life of this patent
Estimating the term…
Abstract
An isolated nucleic acid encoding an FX protein having a serine at position 79, a lysine at position 90, a leucine at position 136, an arginine at position 211, a serine at position 289, and a combination thereof is provided. Cells having a gene encoding a modified FX protein are provided, wherein the cells exhibit a reduced ability to fucosylate a glycoprotein at a first temperature, but exhibit the ability to fucosylate the glycoprotein at a second temperature. Methods and compositions for making glycoproteins with reduced fucosylation are provided.
Claims12
A method for making a glycoprotein, comprising:
- culturing a mammalian cell at a temperature of about 34° C. and in the absence of an external fucose source to express said glycoprotein, wherein the mammalian cell expresses a GDP-4-keto-6-deoxymannose-3,5-epimerase-4-reductase (FX) protein that comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:
- 1, and wherein the FX protein comprises modification relative to SEQ ID NO:
- 1, the modification comprising a first amino acid substitution of L289S and a second amino acid substitution selected from the group consisting of N79S, N90K, P136L, and G211R;
- and
- isolating the glycoprotein from the culture.
A method for making a glycoprotein, comprising:
- culturing a mammalian cell at a temperature of about 34° C. and in the absence of an external fucose source to express said glycoprotein, wherein the mammalian cell expresses an FX protein that comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:
- 1, and wherein the FX protein comprises modification relative to SEQ ID NO:
- 1, the modification comprising the amino acid substitution of L289S;
- and
- isolating the glycoprotein from the culture.
Dependencies are inferred from the claim text.